Microscopes have long served as windows into the hidden world of cells, revealing their shape, activity, and chemistry. Yet ...

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

Genetically engineered cell lines used in biomedical research have long been prone to misidentification and unauthorized use, ...

Researchers ushered in a new chapter for personalized and precise cancer diagnostics using technology that can automatically ...

MIAMI, July 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric ...

Neurona Therapeutics’ epilepsy treatment could be a breakthrough for stem-cell technology. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it ...

Longeveron Inc. (NASDAQ:LGVN) is one of the best meme stocks. On July 21, Longeveron obtained a US patent license for stem cell technology from the University of Miami, which could help in developing ...

Researchers have identified novel molecular mechanisms that help specialized T cells maintain long-term immunity in response ...

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology. The AT2-like cells ...